封面
市场调查报告书
商品编码
1470930

胞外体研究市场:按产品/服务、适应症、应用和最终用户 - 2024-2030 年全球预测

Exosome Research Market by Product & Service (Instruments, Kits & Reagents, Services), Indication (Cancer Indication, Cardiovascular Diseases, Infectious Diseases), Application, End User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

胞外体研究市场规模预估2023年为2.0753亿美元,2024年达2.3098亿美元,预估2030年将达4.5081亿美元,复合年增长率为11.71%。

胞外体是几乎所有细胞类型释放的细胞外囊泡,存在于多种体液中,包括血液、尿液和脑脊髓液。胞外体研究市场包括胞外体分离、鑑定和分析所需的产品和服务。癌症和其他慢性疾病的迅速增加因其诊断和治疗的相关性而刺激了胞外体的研究。胞外体分离和分析技术的进步正在推动市场成长。增加对生命科学研究的投资,特别是了解细胞间通讯和液态切片,正在为市场做出贡献。然而,由于胞外体分离精製方法的标准化尚未取得进展,研究结果各不相同。区分胞外体与其他细胞外囊泡和污染物的技术困难,以及胞外体分离和分析设备的高成本,是市场面临的挑战。此外,扩大用于早期诊断和个人化治疗策略的胞外体生物标记研究正在创造市场机会。创新和标准化胞外体分离和分析技术的开拓是这一市场潜力的主要驱动力。

主要市场统计
基准年[2023] 20753万美元
预测年份 [2024] 23098万美元
预测年份 [2030] 45081万美元
复合年增长率(%) 11.71%

产品和服务 越来越关注用于诊断和治疗应用的胞外体研究服务

胞外体研究设备包括用于胞外体分离和分析的各种设备,包括超速离心机、奈米颗粒追踪分析(NTA)系统、流式细胞技术以及其他用于胞外体表征和定量的专用设备。胞外体研究设备因其高精度、高灵敏度以及高通量高效处理样品的能力而成为首选。胞外体研究套件和试剂包括各种用于分离、染色、追踪和分析胞外体的预包装溶液和化学物质。胞外体研究套件是寻求标准化且可靠的方法以确保实验结果一致的研究人员的首选。胞外体研究服务是指为缺乏资源或专业知识来进行内部胞外体研究的研究人员提供的各种第三方服务。胞外体研究服务通常包括胞外体分离、生物标记分析、表征和定序,这对于诊断、治疗和生物标记发现应用至关重要。

观点:癌症检测胞外体研究的进展

用于癌症检测的胞外体研究旨在了解胞外体在肿瘤发生、进展和转移中的作用。胞外体携带特定的分子货物,包括蛋白质和核酸,反映癌细胞的状态,因此可作为癌症诊断和预后的潜在生物标记。心血管疾病中的胞外体研究与利用胞外体了解这些病理状况背后的病理学过程有关。胞外体正在研究其在细胞间通讯中的作用及其调节血管生成、心臟肥大和心臟疾病发炎等过程的能力。在感染疾病背景下胞外体的研究旨在揭示它们对免疫反应和病原体传播的影响。胞外体含有病原体和病原体衍生分子,与疾病的发展有关,为疫苗和治疗方法的开发提供有用的见解。在神经退化性疾病中,胞外体研究对于了解致病蛋白传播等疾病机制至关重要。胞外体穿过血脑障壁,为有效诊断神经系统和递送药物分子提供了机会。

胞外体研究在应用疫苗开发的广泛应用

生物标记是存在于血液、体液和组织中的生物分子,是正常或异常过程或疾病状态的标誌。胞外体稳定存在于体液中,在癌症、神经退化性疾病、心血管疾病等疾病的诊断和监测中发挥极其重要的作用。组织再生专注于受损组织和器官的修復和替换,源自于干细胞,能够将再生分子转移到受损细胞中,促进癒合和再生。胞外体在免疫反应中发挥重要作用,因为它们正在被研究作为一种新型的疫苗递送系统。胞外体可以模仿病毒颗粒并增强呈现抗原,从而有可能增强对疫苗的免疫反应。

最终用户:将胞外体研究用于医院和临床环境中的诊断目的

由于学术研究机构专注于了解胞外体的生物学功能、应用和治疗潜力,因此构成了胞外体研究的基础。医院和临床实验室主要出于诊断和预后目的进行胞外体研究,因为它们需要强大的、经 FDA 批准的平台和套件,以促进胞外体的准确检测和定量,以用于患者照护。基于胞外体的药物传输系统的潜力和胞外体疗法的发展正在推动製药和生物技术公司研究胞外体。製药和生物技术公司青睐可扩展的生产方法、高纯度分离技术和合规的製造流程。

区域洞察

在美洲地区,胞外体研究得到了专注于治疗应用和诊断开发的公共和私人投资的支持。由于该地区主要企业的强势地位,美国和加拿大是市场成长的主要推动力。欧盟 (EU) 国家正在透过 Horizo​​​​n Europe 等框架大力投资研究和创新,重点是加速生命科学的进步,包括胞外体研究。欧洲、中东和非洲地区的消费者需求倾向于将胞外体研究整合到全面的医疗保健解决方案中。在亚太地区,印度、日本和中国正在提高客户对医疗保健领域新生物技术方法的参与。亚太地区已成为胞外体研究的主要中心,专利申请进展迅速。亚太地区政府对医疗保健支出的日益关注对市场成长做出了重大贡献。

FPNV定位矩阵

FPNV定位矩阵对于评估胞外体研究市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市场占有率分析

市场占有率分析是一种综合工具,可以胞外体研究市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解:

1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。

3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题:

1.胞外体研究市场的市场规模与预测为何?

2.在外胞外体研究市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?

3.胞外体研究市场的技术趋势和法规结构是什么?

4.胞外体研究市场主要厂商的市场占有率为何?

5.进入胞外体研究市场的合适型态和策略手段是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和遗传性疾病盛行率上升
      • 扩大药物发现和开发活动以及对有效药物和基因递送策略的需求
      • 推动基因组和胞外体研究的政府津贴和倡议
    • 抑制因素
      • 需要复杂精密的设备和缺乏熟练的人员
    • 机会
      • 整合先进技术,提高胞外体的效率与速度
      • 患者对个人化医疗策略的偏好
    • 任务
      • 胞外体研究的技术限制与困难
  • 市场区隔分析
    • 产品与服务:胞外体研究服务对于诊断和治疗应用变得越来越重要
    • 适应症:癌症检测胞外体研究的进展
    • 应用:胞外体研究在疫苗开发的广泛应用
    • 最终用户:将胞外体研究用于医院和临床环境中的诊断目的
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章胞外体研究市场(依产品及服务)

  • 装置
  • 套件和试剂
  • 服务

第七章胞外体研究市场(按适应症)

  • 癌症适应症
  • 心血管疾病
  • 感染疾病
  • 神经退化性疾病

第八章胞外体研究市场:依应用分类

  • 生物标誌物
  • 组织再生
  • 疫苗开发

第 9 章胞外体研究市场:依最终使用者分类

  • 学术研究所
  • 医院和临床实验室
  • 製药和生物技术公司

第十章 北美和南美的胞外体研究市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区胞外体研究市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的胞外体研究市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • 创新 Proteomics推出先进的胞外体分离与精製服务
    • 总部位于南卡罗来纳州的 IMCS 与 Tymora Analytical 合作简化胞外体研究
    • AGC Biologics 与慈惠医科大学签署胞外体协议用于特发性肺纤维化 (IPF)计划
  • 战略分析和建议

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-AD36CD897B3A

[191 Pages Report] The Exosome Research Market size was estimated at USD 207.53 million in 2023 and expected to reach USD 230.98 million in 2024, at a CAGR 11.71% to reach USD 450.81 million by 2030.

Exosomes are extracellular vesicles released by virtually all cell types and found in various body fluids, including blood, urine, and cerebrospinal fluid. The exosome research market encompasses the products and services required to isolate, identify, and analyze exosomes. The surge in prevalence of cancer and other chronic diseases is stimulating exosome research due to its diagnostic and therapeutic relevance. The ongoing advancements in technology for isolation and analysis of exosomes is enhancing the market growth. The growing investment in life sciences research, particularly in understanding cell-to-cell communication and liquid biopsies, contributes to the market. However, lack of standardization in exosome isolation and purification methods, leading to variability in research outcomes. Technical difficulties in discriminating exosomes from other extracellular vesicles and contaminants and the high cost of exosome isolation and analysis equipment are challenging factors for the market. Moreover, the expansion of research in exosomal biomarkers for early diagnosis and personalized treatment strategies is creating opportunities in the market. The development of innovative and standardized exosome isolation and analysis techniques are significantly driving potential in the market space.

KEY MARKET STATISTICS
Base Year [2023] USD 207.53 million
Estimated Year [2024] USD 230.98 million
Forecast Year [2030] USD 450.81 million
CAGR (%) 11.71%

Product & Service: Rising emphasis on exosome research services for diagnostics and therapeutics applications

Exosome research instruments encompass the various types of hardware used to isolate and analyze exosomes, including ultracentrifuges, nanoparticle tracking analysis (NTA) systems, flow cytometry, and other specialized equipment for the characterization and quantification of exosomes. Exosome research instruments are preferred by ability to offer precision, sensitivity, and the ability to handle high-throughput samples effectively. Exosome research kits & reagents include a variety of prepackaged solutions and chemicals used in the isolation, staining, tracking, and analysis of exosomes. Exosome research kits are frequently preferred by researchers seeking standardized, reliable methodologies to ensure consistent results across experiments. The exosome research services refers to the various third-party offerings available to researchers that lack the resources or expertise to conduct certain aspects of exosome research in-house. Exosome research services typically include exosome isolation, biomarker analysis, characterization, and sequencing, which are essential for diagnostics, therapeutics, and biomarker discovery applications.

Indication: Advancements in exosome research for cancer detection

Exosome research for cancer indication is directed toward understanding the role of exosomes in tumorigenesis, progression, and metastasis. The exosomes serve as potential biomarkers for cancer diagnosis and prognosis due to the specific molecular cargo they carry, including proteins and nucleic acids that reflect the state of tumor cells. Exosome research for cardiovascular diseases is related to the use of exosomes in understanding the pathophysiological processes underlying these conditions. Exosomes are studied for their role in intercellular communication and their ability to modulate processes such as angiogenesis, cardiac hypertrophy, and inflammation in cardiac conditions. Research on exosomes in the context of infectious diseases aims to uncover the influence of the immune response and pathogen spread. Exosomes contain pathogens or pathogen-derived molecules and play a role in disease pathogenesis, providing insights that can aid vaccine and therapeutic development. In neurodegenerative diseases, exosome research is essential for understanding disease mechanisms, such as the spread of pathogenic proteins. Exosomes cross the blood-brain barrier, offering an opportunity to effectively diagnose and deliver drug molecules to the nervous system.

Application: Broad applications of exosome research for vaccine development

Biomarkers are biological molecules present in the blood, body fluids, or tissues that are sign of a normal or abnormal process or a disease condition. Exosomes have a pivotal role in disease diagnosis and monitoring, particularly for cancer, neurodegenerative, and cardiovascular diseases, owing to their stability and presence in bodily fluids. Tissue regeneration focuses on repairing or replacing damaged tissue and organs and are derived from stem cells due to their ability to transfer regenerative molecules to damaged cells, thus promoting healing and regeneration. Exosomes have a role in the immune response as they are being explored as novel delivery systems for vaccines. Exosomes can mimic virus particles, enhancing antigen presentation, and therefore can potentially boost the immune response to vaccines.

End User: Utilization of exosome research in hospitals and clinical settings for diagnostic purposes

Academic and research institutes form the foundational base for exosome research as it focuses on understanding exosome's biological functions, applications, and therapeutic potential. Hospitals and clinical testing laboratories utilize exosome research primarily for diagnostic and prognostic purposes as it requires robust, FDA-approved platforms and kits to facilitate the accurate detection and quantification of exosomes for patient care. The potential of exosome-based drug delivery systems and the development of exosome therapeutics drive the pharmaceutical and biotechnology companies in exosome research. The pharmaceutical and biotechnology entities favor scalable production methods, high-purity isolation techniques, and regulatory-compliant manufacturing processes.

Regional Insights

In the Americas region, exosome research is bolstered by both public and private investments with a significant focus on therapeutic applications and diagnostic developments. The United States and Canada are significantly bolstering the market growth by the strong position of key players operating in the region. The European Union countries invest heavily in research and innovation through frameworks such as Horizon Europe, laying an emphasis on fostering advancements in life sciences, including exosome research. Consumer needs within the EMEA region gravitate towards integrating exosome studies into comprehensive healthcare solutions. In the APAC region, India, Japan, and China are showing increasing customer engagement with novel biotechnological approaches in healthcare. The APAC region is emerging as a major hub for exosome research, displaying rapid progress in patent filings. The rising focus on healthcare spending by governments in the APAC region significantly contributes to market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Exosome Research Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Exosome Research Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Exosome Research Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Alpha Laboratories by Pace Analytical Services, AMS Biotechnology (Europe) Limited, AMSBIO, BioCat GmbH by AddLife, Creative Biolabs, Cusabio Technology LLC, Fujifilm Holdings Corporation, HiSS Diagnostics GmbH, Lonza Group Ltd., Malvern Panalytical Ltd., MBL International Corporation, Miltenyi Biotec B.V. & Co. KG, NanoSomiX, Inc., Norgen Biotek Corp., Nx Pharmagen Inc., QIAGEN N.V., System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Exosome Research Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Instruments
    • Kits & Reagents
    • Services
  • Indication
    • Cancer Indication
      • Breast Cancer
      • Colorectal Cancer
      • Lung Cancer
      • Prostate Cancer
    • Cardiovascular Diseases
    • Infectious Diseases
    • Neurodegenerative Diseases
  • Application
    • Biomarkers
    • Tissue Regeneration
    • Vaccine Development
  • End User
    • Academic & Research Institutes
    • Hospitals & Clinical Testing Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Exosome Research Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Exosome Research Market?

3. What are the technology trends and regulatory frameworks in the Exosome Research Market?

4. What is the market share of the leading vendors in the Exosome Research Market?

5. Which modes and strategic moves are suitable for entering the Exosome Research Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease conditions and genetic disorders
      • 5.1.1.2. Expanding drug discovery and development activities and the need for efficient drug and gene delivery strategies
      • 5.1.1.3. Government grants and initiatives to advance genome and exosome research
    • 5.1.2. Restraints
      • 5.1.2.1. Need for complex and sophisticated equipment and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies to streamline and accelerate exosome research
      • 5.1.3.2. Patient preference for personalized medicine strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and difficulties of exosome research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Rising emphasis on exosome research services for diagnostics and therapeutics applications
    • 5.2.2. Indication: Advancements in exosome research for cancer detection
    • 5.2.3. Application: Broad applications of exosome research for vaccine development
    • 5.2.4. End User: Utilization of exosome research in hospitals and clinical settings for diagnostic purposes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Exosome Research Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits & Reagents
  • 6.4. Services

7. Exosome Research Market, by Indication

  • 7.1. Introduction
  • 7.2. Cancer Indication
  • 7.3. Cardiovascular Diseases
  • 7.4. Infectious Diseases
  • 7.5. Neurodegenerative Diseases

8. Exosome Research Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarkers
  • 8.3. Tissue Regeneration
  • 8.4. Vaccine Development

9. Exosome Research Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Clinical Testing Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Exosome Research Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Exosome Research Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Exosome Research Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Creative Proteomics Launches Advanced Exosome Isolation and Purification Service
    • 13.3.2. South Carolina-Based IMCS, Tymora Analytical Partner To Streamline Exosome Research
    • 13.3.3. AGC Biologics Signs Exosome Agreement with The Jikei University in Japan for Idiopathic Pulmonary Fibrosis (IPF) Project
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EXOSOME RESEARCH MARKET RESEARCH PROCESS
  • FIGURE 2. EXOSOME RESEARCH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EXOSOME RESEARCH MARKET DYNAMICS
  • FIGURE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXOSOME RESEARCH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY EXOSOME RES